1-4 of 4
Constantin N. Baxevanis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses

Free
Maria Salagianni, Eftychia Lekka, Ardiana Moustaki, Eleni G. Iliopoulou, Constantin N. Baxevanis, Michael Papamichail, Sonia A. Perez
Journal: The Journal of Immunology
J Immunol (2011) 186 (6): 3327–3335.
https://doi.org/10.4049/jimmunol.1000652
Published: 15 March 2011
View articletitled, NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses
Open the PDF for NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses in another window
Add to Citation Manager for NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses
Includes: Supplementary data
Journal Articles

Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties

Free
Angelos D. Gritzapis, Ioannis F. Voutsas, Eftychia Lekka, Nikolaos Tsavaris, Ioannis Missitzis, Panagiota Sotiropoulou, Sonia Perez, Michael Papamichail, Constantin N. Baxevanis
Journal: The Journal of Immunology
J Immunol (2008) 181 (1): 146–154.
https://doi.org/10.4049/jimmunol.181.1.146
Published: 01 July 2008
View articletitled, Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
Open the PDF for Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties in another window
Add to Citation Manager for Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
Journal Articles

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18

Free
Constantin N. Baxevanis, Angelos D. Gritzapis, Michael Papamichail
Journal: The Journal of Immunology
J Immunol (2003) 171 (6): 2953–2959.
https://doi.org/10.4049/jimmunol.171.6.2953
Published: 15 September 2003
View articletitled, In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18
Open the PDF for In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 in another window
Add to Citation Manager for In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18
Journal Articles

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

Free
Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania E. Tsitsilonis, Angelos D. Gritzapis, Roula Sotiriadou, Michael Papamichail
Journal: The Journal of Immunology
J Immunol (2000) 164 (7): 3902–3912.
https://doi.org/10.4049/jimmunol.164.7.3902
Published: 01 April 2000
View articletitled, Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor
Open the PDF for Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor in another window
Add to Citation Manager for Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor